Correlagen to Launch Genetic Cardiovascular Disease Assay on Helicos Platform This Month | GenomeWeb

By Julia Karow

This article was originally published Oct. 5.

Genetic testing company Correlagen Diagnostics plans to launch a comprehensive assay for genetic cardiovascular disease this month that will run on a Helicos BioSciences' sequencing platform in its CLIA lab, In Sequence has learned.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.